On how US President Donald Trump's protectionist policies may affect the IT and pharma stocks, Rahul Ajmera, CEO, US Office, IIFL Institutional Equities, said Trump has been in office for merely four weeks and it is too early to speculate.
first published: Feb 22, 2017 12:52 pm
A collection of the most-viewed Moneycontrol videos.
You are already a Moneycontrol Pro user.

